Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
LOL Slojab,
You fell into the trap. Did I mispell some stuff .... my bad .... and ... don't care. No one is obligated to read what I have to say. I think some are in love here.
Best to take the Mark Twain approach. What with not even 5th grade english comprehension and obvious no business understanding .... can't figure out that LOIs are totally worthless ...... even though an idiot can google it to see the same ........ and it is irrelevant what the LOI is for. LOI's don't mean diddly. And honestly before leveraging ignore ..... I can't say that I ever saw an actual post of value actually about ECSL ... ya know .. the topic of the board.
And I don't bother with the replies button any more either as .... if reply is someone I feel offers value to the discussion and I'd like to hear from ..... then I'll surely see it. So zeroes ..... get zero of my time.
Amigo Mike
Size bidder for 5K shares just under the market this morning at $6.80.
Personally don't think this stock should be any less than $10 and should be at least $20 after the coccidiosis test. But goes to show if you don't get the word out ... you get what you get.
5K bidder must be nutz given no one talking about ZIVO and CEO doesn't know what he's doing .... LOL.
Been looking at coccidiosis treatments and animal pharmas ....... were I Payne I'd be looking to target Zoetis, Merck Animal Health and Elanco for this.
Pretty sure Payne is on a first name basis with the C Suite at Zoetis. Payne is former CEO of Bayer Animal Health .... whose parent company happens to be Elanco. I mean far be it from me to assume Payne don't know people at Elanco eh ? Payne is also former CEO of an animal hospital chain and current ZIVO BoD member is CFO of animal hospital chain. I'm sure access to the big boyz isn't a problem.
Now getting big boyz on board for a license or co development agreement is a different story that some people seem to think is a signature ready type thing. I guarantee you is isn't that way. Been there and lived that with numerous small biotechs over the last couple decades.
I still think ZIVO needs to issue more information on the coccidiosis test. Details of the test. compares, value. All that ..... there's also question of what exactly the feed ingredient is ..... whether it is the base dried algae ... and modified version, a synthetic version. Production of it in quantity necessary to support broad distribution .... etc etc etc.
Amigo Mike
12BeRich,
The date being referenced ..... 12/29/2023 ..... is the actual date on the deed documents.
The signatures on the documents are dated 1/11/2024.
Anyway .....
.... It is looking like ZIVO is purposely being held under $10 with lack of action. That is a psychological number that we need to maintain above for next move.
Not helped by ZIVO silence on the tests here is not good for us ... or the company.
Amigo Mike
I agree,
But feels far too "immediate" to me. We all have same concerns about this company. But I'm not sure anyone here expected to see immediately anything besides of course reaction of the stock.
Amigo Mike
Attack ?
That is hilarious. I didn't say anything other than selling out and deciding to bash the company. 1 day you are bullish, the next you are saying the company is worthless. And ya did say the "company is worthless".
Ah,
So put another way .... ya got your money back and now you don't believe in anything and bash the stock. Company is "worthless". Got it.
Yes mgmt of this company leaves so so much to be desired. No question about that. And the level of communication is atrocious.
The test result news was a week ago. Dunno why anyone would expect news on partner or license immediately. But to each his own.
Amigo Mike
WOW,
That is a complete 180 from prior ........ so ....... what's changed ?
Well I guess you aren't fully misquoting ....
..... it sez "sales pipeline growth" .... which is nice ... but within the first 5 months of working together which was well over a year ago now.
Sale Pipeline growth is fancy way of saying sales leads. And who knows what $4B means. Just typical for ECSL. And do you really think ECSL has a "$4 Billion" potential sales pipeline i.e. revenue to ECSL qtrly, annually, lifetime ? Ah huh ..... I have a bridge for sale. Cheap too.
Sales leads are just that .... leads .... not sales. Which the fins prove haven't materialized thus far.
Like I said .... unless there are millions in revenues coming from the additive .... it doesn't move the needle. And I'll add millions in sales .... PROFITABLY.
Amigo Mike
TKS,
You are misquoting ..... read the words carefully.
Don't you wonder why this stock isn't over $1 when Lorton deal is closed ..... biggest, most verifiable and significant in company history and a legitimate petroleum industry name dropped ? Plus additive sales are growing exponentially according to non credible sources ?
Just over 2 weeks to next ECSL qtrly disclosure. Probably 3 weeks cause Mills can't file on time but magically can file 5 days later every qtr. Takes time to figure out what not to tell investors. The "Subsequent Events" section will be especially interesting.
Amigo Mike
Gwinner,
CNBC doesn't cover pink/otc companies.
I am looking for INDUSTRY PUBLICATIONS ... interviews .... BUZZ .... OUTRAGE FROM PEOPLE THE INDUSTRY NEEDS THIS.
This need to be widely distributed and understood and people need to understand the implications and what it means for HUMAN FOOD SUPPLY.
Amigo Mike
Algaeboy,
The ingredient is mixed with the chicken feed. What it actually is .... the raw algal biomass dried and powdered .... or a modified version .... I can't say that I know that specifically. My understanding is this is covered by worldwide patents .... but you can't patent naturally occurring substances. So there is certainly process.
Either way, I agree with you 100%. ZIVO NEEDS TO PUT OUT MORE INFORMATION ON THE DETAILS OF THIS TEST. PAINT THE PICTURE FOR THE MARKETS. PAINT THE PICTURE OF THE INDUSTRY AND MARKET DEMANDS FOR NON ANTIBIOTIC TREATMENTS.
It always seems to me that ZIVO mgmt and BoD is totally clueless that they are a public company and have no money. YOU DON"T WANT TO RAISE MONEY AT THE LOWEST PRICES which ZIVO has been forced to do multiple times. THEY CONTROL THE SILENCE AND THE MESSAGE. If they haven't learned in 10+ years ... SILENCE DOESN"T WORK. And who knows, maybe there are OTHER COMPANIES THAT MIGHT BE INTERESTED IN GETTING INVOLVED. If you don't speak up and represent yourself, IS SOMEONE ELSE GOING TO DO IT ? Not likely.
This is a bit why I am leaning toward ZIVO company sale as a whole at this point. They've proven the chicken candidate in real world growing conditions. By now they should have proven others .... but it is what it is .... I can see these guys getting a license or whatever .... but then going through this process again for another candidate ..... MULTIPLE MORE YEARS FOR NEXT CANDIDATE ISN"T GOING TO CUT IT. They rely on everyone else to do this stuff. It takes at least multiple times longer than a company with inhouse staff. Dunno what the PHDs in Fort Myers do but if they aren't working other candidates and options .... then they are worthless. It is designed to be sold ..... SELL IT.
Be interesting to see what happens with $10 this week. IMO, it should be vigorously defended by investors as double digits is a big deal for a stock that is risin out of the abyss. Maintaining $10 not only sets stage for next move .... but if by chance ZIVO tries raising more money .... THE DILUTIVE EFFECT IS VASTLY DIFFERENT.
So ..... let's see what happens here. Someone is taking in a ton of warrants that have a $33 strike creating alot of leverage but the stock has got to move up for that to pay off.
ZIVO going silent IS NOT THE ANSWER.
Amigo Mike
First industry article that I've seen.
https://www.myvetcandy.com/blog/2024/1/27/biotech-breakthrough-zivo-bioscience-unveils-revolutionary-non-antibiotic-treatment-for-poultry-disease
Payne needs to release more trial result info.
And there needs to be a dozen of these articles in industry publications.
Amigo Mike
Just1MoreShare,
Your best indicator of success is your mgmt and your business and growth plan/path. And as an investor an ever vigilant view of as much info as you can find. Especially with small less established companies you gotta pay attention closely.
What exchange you are on doesn't ensure any of level of success.
I'll leave it at that.
Amigo Mike
Yeah,
I'm pretty sure they didn't do the split proper on the public warrants ..... cause the SEC filings make it look like they did.
And there are those pesky details around registered shares .... which the offering and warrants were originally covered by a specific number of registered shares. ZIVO would have a problem were those warrants to become exercisable as they can't issue 3 million shares on them under the registration statement at least IMO. As noted prior to RS ZIVO reported nearly 3 million of these ... after ... they are reporting 495k. So they need to correct / clarify these. Marchiando still silent. And strangely no response from ZIVO legal who usually at least responds with at least acknowledgement of receipt.
Hell I don't care if they screwed it up and maybe now you get 1/6th of a share on warrant exercise ..... whatever the current terms are, just need to know because if this thing GOES TO THE MOON .... it is serious monetary difference.
Case in point ... if you owned 10,000 warrants pre split of course the strike was $5.50. Now saying the strike is $33 but no RS of the warrants happened.
IMO, it should be 1,667 warrants at $33.
But if ZIVO for some reason rockets to say $50 like we would all like .... the warrant should certainly bridge the gap between strike and price meaning it should be worth $17 / warrant. Well ..... owning 10,000 of these is big money ... $170K ..... owning 1,667 of those is still big money at $28.3K ..... but a MASSIVE difference.
Just need clarity on the outstanding and the terms. Maybe I'm totally off base but my understanding is these all fit under a registration statement filed with the SEC for a specific number of shares which have since gone through an RS.
Amigo Mike
Someone is surely working on creating a highly leveraged position in those warrants. One that would take a sharp move upward in the stock to cash in on.
There is time decay on these just like options. Right now they are on fire and the demand is there.
Amigo Mike
Just1MoreShare,
Those are easy. But you selected one of multiple sets of requirements that a company can qualify under.
And those related to capital structure and business activities are just 1 component of many to be listed on Nasdaq. There are also different layers of Nasdaq listing. ECSL likely initially list on the lowest Nasdaq tier ... Capital Markets. But it's Nasdaq so don't really matter which one.
https://listingcenter.nasdaq.com/assets/initialguide.pdf
It is really only interesting after ECSL begins proper SEC registration and files audited fins and provides all the nitty details on its business dealings. Much of the shady BS has to see the light of day in disclosures. See Page 13 and beyond. Independent BoD, CFO, qualified financial experts, corporate governance, annual meetings and votes ..... ya know .... all that fun stuff. For example, just the PR on Lorton purchase wouldn't fly if ECSL was on Nasdaq. A Wall Street analyst would shred that to pieces. Not to mention having to file 8K within 4 days to provide any missing details.
Like I said, EVERYONE will know when the Nasdaq listing is possible. Lotta changes needed that have to happen out in the open. I'm all for it ... bring it !!!!
Amigo Mike
So who is scooping all the warrants today ?
Over 250K traded so far with another 42k available on the ask at .45.
Amigo Mike
Welp,
Did some chart work last night .... and to me ...... we are probably in a resistance zone ..... ZIVO spent a few months in the $10-$13 range starting in July before death spiral starting in mid September to the November lows.
So not a surprise to me if there is some consolidation here for a bit between $10 and $13. That said ... anything can happen. But I think the $10 level should be vigorously defended by ZIVO investors if need be. And still think minimum target is $20 prior to hearing a license type PR as that is where the stock was at the time of the first test failure before dropping to the aforementioned area in July.
I would really like to see a more PR from ZIVO on the chicken test highlighting its details and results relative to the standards of today. Can't go silent here for months. In addition, they should be all over social media and industry publications for interviews and generating buzz. My guess is they are clueless on that aspect.
So ZIVO NEEDS TO MARKET ITSELF AND REALIZE WHAT INFORMATION DOES FOR THE COMPANY AND ITS FUTURE.
Amigo Mike
Welp,
After the morning action ZIVO is back in positive territory and uptick ..... and honestly looking very very thin at the moment. I suppose those that wanted to do something this morning went and did their business ..... but back to super thin and I suspect a whisper moves this stock one way or another.
Need ZIVO to bring more news to the markets. No fluffy BS. Meat and potatoes.
Amigo Mike
CWard,
Far be it from me to throw cold water on things ..... but stock action is already stale and cold. Hell I would like to see ECSL run past $1 just like you. Quality name for sure.
Why you say ? This morning's PR is basically a "name drop". That is more or less what you learned .... AND ... M O U ..... rather than me discussing ... look it up. Basically in the category of "worthless LOI" .... M O U .... is just about the same thing ..... 2 parties agree to do something ... "maybe".
"to potentially develop". <=== another maybe. These are typically non binding agreements.
Its been 3 1/2 years ? Still haven't figured out "how to develop best and jointly the newly acquired land at Port Tampa, Florida. " ???
January 2023 Shareholder update
This dump ... hell .... LOL .... I didn't expect it but now considering rolling back in with buys .....
Warrants getting more action today as well. Could be some stock selling to buy warrants but ultimately the warrants need buying the stock to continue.
Amigo Mike
Gee,
I hope my note wasn't taken as .... go to town .... selling or outright sell. Some big offers pushing down since my trim note. If you are trying to sell a little .... this is so tight .... ya need to bleed out in small chunks ... not thousands of shares at a time.
I'm still in the camp this keeps rising to at least $20 but folks certainly need to do you and do whatchya got to.
This is why the clowns need some followup PR and buzz. There is ZERO buzz on social media on ZIVO. The news should be sent out to all poultry industry publications.
Amigo Mike
Nice bounce out of the gate again this morning ..... following recent patterns.
In the spirit of disclosure ..... and for anyone that might be tailing what I am doing ..... having bought swing position at avg 62 cents .... I bled out 10% of my swing position at $12.50. Covering full swing cost and taking some profit out. Deciding on what's next. But 20 bags is probably one of the best outcomes I think I've ever had for a swing trade. I've had 100 bag+ long term winners but for short term swings ... this one has been quite the trade.
I'm still the in camp ... this damn thing should be $20 on this positive test result by itself. Again ZIVO thin on details and timing of anything for next steps. But $20 just put the stock back where it was when the first test failed. Now with those positive results in hand .... there is plenty of reason to believe this thing should be higher.
Amigo Mike
There is no change in requirements Tony ......... have to meet initial uplisting minimums.
Amigo Mike
Yes I think there is more to come on this from ZIVO. Twas a bit too short on details in my book.
Late buyers took out the supply set up at just over $10 just before close but no added buying to push it further. Plus warrant action topped 100,000.
5 minute chart has new flag on it that would seemingly indicate more upside to come but it is anyone guess.
I'm still in the camp ZIVO should be minimum $20 after this news ..... and more likely $50 if license is on tap.
I also think ZIVO should be on the phone with Armistice Capital for a discussion.
Amigo Mike
Sure looks to me like someone trying to hold the line at the $10 area.
Not unlike yesterday someone trying to hold it in high $8s.
Almost 100,000 warrants traded so far today and strong uptick in bid.
Now are there 3 million warrants out .... or 500,000 ... LOL ... ZIVO ? Anyone ? LOL. Oh Mr CFO ? WASSUP ?
Amigo Mike
Pretty sure all the top 5 have coccidiosis vaccine or treatments.
https://www.statista.com/statistics/260190/leading-animal-health-providers-based-on-revenue/#:~:text=Today%2C%20U.S.%20pharmaceutical%20manufacturer%20Zoetis,it%20became%20an%20independent%20company.
I'd take a license with any of them. (or buyout but there are broader implications).
Amigo Mike
I'm curious how you are arriving at ZIVO wants to .... go out with a bang ! .....
They've offered no indication of being interested in a buyout. Of course were a $250 million offer presented to the company today ..... they'd certainly have to consider. LOL ... would like to see that announcement tomorrow ..... LOL.
Payne is driving the bus. Unfortunately he is late 70s if I remember correct and there is no apparent successor .... so in my mind ... yes they should be driving towards a buyout and I'd be happy with your numbers although as I've stated before .... were ZIVO to prove out a vertical or 2 ..... IMO ... it is worth $1+ Billion. (yes that is BILLION) . Put that in your calculator ... LOL. There are multiple verticals possible here in both human and animal health. If you've been watching the news lately alot of discussion on "gut health". Guess what .... ZIVO. For both human and animal targets. Plus outside the gut ...... INFLAMMATION is where almost all of this is rooted.
I think a lotta people still lose money at that buyout number. Remember there are 2 RS in there that represent 1 for 480 if you owned the stock before the Nasdaq uplist. So even if you had 10 cents cost basis wayyyyyy back ..... that is $48.00 per share now. I don't think there are many with that type of cost basis. 20 cents is $96.00 / share now. So anyone that held and didn't flip shares over the years like myself and Weasel ..... is still losing his shirt.
Amigo Mike
Warrants getting hit hard today ..... buyers I am guessing see the leverage and arbitrage potential.
Amigo Mike
I am not happy to say it Gwinner,
But I don't think ZIVO is interested in selling the company. At least not now. Just a gut feeling but ..... I'd certainly prefer it at the moment given the history.
Amigo Mike
I can't fault anything you are saying but .... IMO .... this is not a "sell the news" point in time.
The market cap is $27 million for a breakthrough in non antibiotic treatment of chickens. Everyone and his mother wants antibiotics out of treatment for feed animals.
This treatment has an already determined USDA pathway that we know is far less of a PITA compared to dealing with the FDA.
And ZIVO has had a major animal pharma looking at this for over a year.
We know ZIVO runs fast and hard and then periods of nothingness. I think it is time for major PR campaign. And time to hold this for a bit at worst to see what happens. It is of course unique to everyone's own situation but IMO ..... this test was the FINAL test to prove out in full scale growing conditions over the full growth cycle. This was final stage test.
This is a multi billion market as the PR states.
The chart was ridiculously over sold for months ..... I don't think it is ridiculously overbought comparatively speaking. And $50 a share just gets ZIVO back to a market cap that it previous maintained for a long time prior to 2023 disaster. Yeah I know it doesn't work that way .... but ...... seems to me it is time to OWN it .... vs sell it.
Amigo Mike
Geezus,
There is ZERO stocktwits and twitter chatter on $ZIVO at all.
Amigo Mike
Welp,
Just over 5000 shares traded so far. Have to say that I'm disappointed but ZIVO pissed off alot of people and now on pinkies ..... didn't maintain communications with investors ...... and here we struggling to break $10 on the biggest news literally ... in company history. Product validation.
Welp I still see no reason to sell. Hopefully ZIVO has more for investors in the near term and doesn't go silent here for another 6 months.
Still breaking every one of my own swing trading rules and have not sold 1 swing share yet.
Amigo Mike
Is it my opinion that ZIVO or more specifically Payne ..... is talking with a top 5 animal pharma. No rinky dinky name that nobody has herd of ....... top shelf pharma. Frankly I hope he is providing the results TO MORE THAN 1 .... as several have treatment options available.
I AM NOT OPPOSED TO BIDDING WAR. Hell I would want Zoetis to pay double for already having inside glimpse and doing nothing about it.
Amigo Mike
So which one of you have contacts in the poultry industry to start spreading this news. Anything we can do to get the word out would be beneficial IMO.
Also I hope that it is NOT Zoetis. Those idiots have already seen what the ZIVO product candidate can do .... and IMO ... have had their shot .... sat on their hands and did not come with appropriate support .... all IMO ....... I am looking at others in the top 5 animal pharmas.
Amigo Mike
LOL,
I'll take that as well.
This is a revolutionary change for the industry ..... and not just chickens. IMO it is worth well north of where the stock is right now. MANY multiples. Even more than $77. But of course can't get ahead of this. The stock was roughly $70/share spilt adjusted before Dahl uplisted and allowed ZIVO investors to get raped with that uplist and raise 2 1/2 years ago.
Some of us have been waiting on a moment like this for nearly 20 years. It has been a long time coming and lotta wasted time. It is time for this train to leave the station and BRING IT.
Amigo Mike
Quite frankly,
There is no reason to be selling this stock today. This should be no less than $20 now.
With license talk in play .... and meets or exceeds current treatment options at no less than cost parity ...... I still think a minimum $50 is more appropriate which only puts ZIVO near the historical market cap that it previously maintained. But now, has a legit product candidate to bring to market with large scale validation ready for USDA approval process and license.
Only thing missing there is ... advanced talks with global animal health company. We already know at least 1 was involved in the prior test. So it is time for the rubber to meet the road here.
Amigo Mike
ZIVO Bioscience Reports Positive Efficacy Results from 42-Day Validation Study with Non-Antibiotic Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens
JAN 23, 2024
BLOOMFIELD HILLS, Mich.--(BUSINESS WIRE)-- Zivo Bioscience, Inc. (OTC PINK: ZIVO) (the “Company”), a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, announces positive efficacy results following its recent 42-day coccidiosis challenge study further demonstrating the effectiveness of its novel immune-modulating treatment for coccidiosis in broiler chickens. ZIVO’s product candidate for use in poultry feed is designed to boost immune response, allowing birds to effectively combat coccidiosis and reduce the negative effects of the disease without the use of antibiotics. With these and earlier test results, ZIVO will pursue a partnership with a global animal health company for commercializing its coccidiosis product.
The study design was similar to that of a previously successful 28-day challenge study but was extended through 42 days to replicate real-world conditions of the broiler production industry. The results of the study in which the ZIVO treatment groups and a placebo control were blinded to the independent study contractor confirm previously reported positive effects of ZIVO’s non-antibiotic alternative for maintaining broiler health against coccidiosis. Notably, the study also showed that the performance of ZIVO’s product candidate was comparable to that of a market leading anticoccidial product.
“We are delighted to report results that validate our prior 28-day study in broiler chickens, and we are particularly excited to report that our product performance compared favorably to a market leading product containing an antibiotic and an anti-coccidial chemical. The outcomes of our studies demonstrate that our coccidiosis treatment is efficacious in real-world conditions, yet without the undesirable characteristics associated with antibiotics and chemicals,” said John Payne, Chairman and Chief Executive Officer of ZIVO Bioscience.
“Not only do our results show our candidate’s effectiveness in counteracting or eliminating adverse effects of coccidiosis on gastrointestinal health of broiler chickens, we are confident that similar results will be obtained in the commercial broiler production environment at cost parity with conventional antibiotic and antimicrobial interventions. As a result, our product exhibits promising potential to revolutionize poultry health management. Our next step is to use these results to engage a global animal health partner to complete licensing through the USDA and commercialize the product,” Mr. Payne added.
About Coccidiosis
Coccidiosis is a protozoal disease that causes diarrhea, weight loss, decreased performance and increased mortality in poultry. This disease represents a significant economic challenge for the global poultry industry, as indicated by a 2020 study that estimated annual costs ranging from $10 billion to $17 billioni. Products for treating coccidiosis are mostly antibiotic- or ionophore-based, and no significant new commercial technology has been introduced in the past 60 years. The global poultry industry spends more than $1.5 billion annually on coccidiosis control, primarily using decades-old compounds that industry and consumers alike wish to replace due to the risks of developing drug resistance. Coccidiosis is a common disease for chickens, especially among young chicks, and can be fatal or result in compromised digestion.
Yeah Gwinner,
A little "flurry" of buying into the close at $8.5925. Nice !
And yeah .... was surprised to see warrants go off. Looked like maybe 1 buyer scooping all up to 46 cents and last 4K at 40 cents. I've also been running scenarios on what happens with those warrants ..... they are not "in the money" til $33 / share ...... but they still have almost 2 1/2 years on them.
Amigo Mike